The Russian National Research Technological University (NUST) MISA awarded a grant of 60 million rubles for the development of innovative cancer drugs. It is reported by “Interfax” referring to the press service of the University.
«A group of scientists led MISA NUST Doctor of Science Alexander Mazhuga starts to develop unique in Russia and in the world of drugs against cancer on the basis of magnetite nanoparticles. The volume of financing of the project – 60 million rubles for the first two years, the grant has been won “, – stated in a press release.
magnetite nanoparticles can be used for accurate diagnosis of cancer, and for the highly effective treatment of the tumor – for delivery of the drug directly into a cancer cell. In addition, with the help of magnetic resonance imaging nanoparticles allow saving visualize the tumor, the report said.
«Our priority – is the development of diagnostic solutions based on magnetite, which, on the one hand, effectively and without extra dose elicited tumor would, on the other hand, easily and quickly be completely eliminated from the body, “- said the head of the research group Alexander Mazhuga.
In the near future efforts will be directed scientists to find solutions against liver cancer and prostate which are among the five most common cancers. The work will be conducted in the new laboratory of the University “Biomedical nanomaterials».
No comments:
Post a Comment